MMSI
Merit Medical Systems, Inc. NASDAQ Listed May 14, 1990$67.22
+3.03%
vs $65.24
Mkt Cap $4.1B
52w Low $60.31
19.4% of range
52w High $96.01
50d MA $65.30
200d MA $77.66
P/E (TTM)
31.6x
EV/EBITDA
13.3x
P/B
2.5x
Debt/Equity
0.6x
ROE
8.1%
P/FCF
18.8x
RSI (14)
63.10
ATR (14)
$1.94
Beta
0.65
50d MA
$65.30
200d MA
$77.66
Avg Volume
769.9K
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
1600 West Merit Parkway · South Jordan, UT 84095 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | AMC | 0.84 | 0.94 | +11.9% | 68.18 | -1.7% | -9.0% | +0.0% | -2.5% | +2.0% | +1.1% | — |
| Feb 24, 2026 | AMC | 0.96 | 1.04 | +8.3% | 82.43 | +1.6% | -3.9% | -1.5% | -1.1% | -0.9% | -2.2% | — |
| Oct 30, 2025 | AMC | 0.82 | 0.92 | +12.2% | 83.04 | +7.0% | +5.4% | -0.2% | +1.3% | -1.5% | -0.7% | — |
| Jul 30, 2025 | AMC | 0.86 | 1.01 | +17.4% | 82.96 | +2.2% | +2.3% | -0.1% | +0.7% | -1.0% | -1.1% | — |
| Apr 24, 2025 | AMC | 0.75 | 0.86 | +14.8% | 94.67 | -3.9% | -0.1% | +0.9% | -0.7% | -0.3% | -1.3% | — |
| Feb 25, 2025 | AMC | 0.82 | 0.93 | +13.4% | 102.03 | -3.4% | -1.5% | -1.9% | +3.6% | +1.0% | -1.1% | — |
| Oct 30, 2024 | AMC | 0.80 | 0.86 | +7.5% | 94.90 | +1.2% | +4.0% | +0.1% | +0.3% | -0.3% | +3.7% | — |
| Aug 1, 2024 | AMC | 0.88 | 0.92 | +4.5% | 84.12 | +3.5% | +5.5% | -1.5% | +2.4% | -1.0% | +2.4% | — |
| Apr 30, 2024 | AMC | 0.71 | 0.77 | +8.5% | 74.10 | +0.8% | +3.4% | +0.5% | +2.5% | +0.7% | +1.2% | — |
| Feb 28, 2024 | AMC | 0.77 | 0.81 | +5.2% | 80.13 | +1.3% | -4.9% | +0.1% | +0.3% | -1.8% | -0.3% | — |
| Oct 26, 2023 | AMC | 0.65 | 0.75 | +15.4% | 63.49 | +5.5% | +8.7% | -3.7% | +3.4% | +3.4% | -0.6% | — |
| Jul 25, 2023 | AMC | 0.75 | 0.81 | +8.0% | 81.53 | -4.3% | -11.1% | -0.2% | +1.5% | +1.6% | -0.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 1 | Needham | Maintains | Buy → Buy | — | $68.18 | $67.00 | -1.7% | -9.0% | +0.0% | -2.5% | +2.0% | +1.1% |
| May 1 | Canaccord Genuity | Maintains | Buy → Buy | — | $68.18 | $67.00 | -1.7% | -9.0% | +0.0% | -2.5% | +2.0% | +1.1% |
| May 1 | JP Morgan | Maintains | Overweight → Overweight | — | $68.18 | $67.00 | -1.7% | -9.0% | +0.0% | -2.5% | +2.0% | +1.1% |
| May 1 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $68.18 | $67.00 | -1.7% | -9.0% | +0.0% | -2.5% | +2.0% | +1.1% |
| Apr 20 | Barrington Research | Maintains | Outperform → Outperform | — | $70.93 | $70.56 | -0.5% | -1.6% | -2.8% | +2.7% | -1.6% | -0.0% |
| Apr 17 | Piper Sandler | Maintains | Overweight → Overweight | — | $70.10 | $70.83 | +1.0% | +1.2% | -1.6% | -2.8% | +2.7% | -1.6% |
| Apr 7 | Canaccord Genuity | Maintains | Buy → Buy | — | $67.81 | $67.36 | -0.7% | -0.6% | +2.7% | -0.9% | -0.6% | +3.4% |
| Apr 1 | Needham | Maintains | Buy → Buy | — | $68.93 | $69.45 | +0.8% | -1.0% | -0.8% | +0.2% | -0.6% | +2.7% |
| Feb 26 | Wells Fargo | Downgrade | Overweight → Equal Weight | — | $79.23 | $78.28 | -1.2% | -1.5% | -1.1% | -0.9% | -2.2% | -0.9% |
| Feb 25 | Barrington Research | Maintains | Outperform → Outperform | — | $82.43 | $83.76 | +1.6% | -3.9% | -1.5% | -1.1% | -0.9% | -2.2% |
| Feb 25 | Needham | Maintains | Buy → Buy | — | $82.43 | $83.76 | +1.6% | -3.9% | -1.5% | -1.1% | -0.9% | -2.2% |
| Feb 18 | Piper Sandler | Maintains | Overweight → Overweight | — | $81.59 | $81.09 | -0.6% | +1.7% | -1.4% | +0.5% | -0.7% | +1.0% |
| Jan 9 | Needham | Maintains | Buy → Buy | — | $93.18 | $91.61 | -1.7% | -7.3% | -3.6% | -2.6% | +0.8% | -1.7% |
| Dec 17 | Canaccord Genuity | Maintains | Buy → Buy | — | $86.85 | $86.85 | +0.0% | +0.4% | +0.3% | +0.3% | +0.3% | -0.3% |
| Nov 14 | Canaccord Genuity | Maintains | Buy → Buy | — | $87.40 | $80.03 | -8.4% | -2.6% | +0.8% | -1.9% | -0.6% | +1.4% |
| Nov 14 | Barrington Research | Maintains | Outperform → Outperform | — | $87.40 | $80.03 | -8.4% | -2.6% | +0.8% | -1.9% | -0.6% | +1.4% |
| Nov 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $87.40 | $80.03 | -8.4% | -2.6% | +0.8% | -1.9% | -0.6% | +1.4% |
| Oct 31 | Piper Sandler | Maintains | Overweight → Overweight | — | $83.04 | $88.86 | +7.0% | +5.4% | -0.2% | +1.3% | -1.5% | -0.7% |
| Oct 31 | Needham | Maintains | Buy → Buy | — | $83.04 | $88.86 | +7.0% | +5.4% | -0.2% | +1.3% | -1.5% | -0.7% |
| Oct 31 | Barrington Research | Maintains | Outperform → Outperform | — | $83.04 | $88.86 | +7.0% | +5.4% | -0.2% | +1.3% | -1.5% | -0.7% |
| Oct 16 | Canaccord Genuity | Maintains | Buy → Buy | — | $80.47 | $81.62 | +1.4% | +0.4% | +1.3% | +1.6% | +1.1% | +0.4% |
| Oct 7 | Barrington Research | Maintains | Outperform → Outperform | — | $83.31 | $83.93 | +0.7% | -0.7% | +1.3% | -1.5% | -4.2% | +0.6% |
| Sep 23 | Barrington Research | Maintains | Outperform → Outperform | — | $83.59 | $83.54 | -0.1% | +0.2% | -0.8% | -3.6% | +0.2% | +0.8% |
| Jul 31 | Wells Fargo | Maintains | Overweight → Overweight | — | $82.96 | $84.75 | +2.2% | +2.3% | -0.1% | +0.7% | -1.0% | -1.1% |
| Jul 31 | Barrington Research | Maintains | Outperform → Outperform | — | $82.96 | $84.75 | +2.2% | +2.3% | -0.1% | +0.7% | -1.0% | -1.1% |
| Jul 31 | Piper Sandler | Maintains | Overweight → Overweight | — | $82.96 | $84.75 | +2.2% | +2.3% | -0.1% | +0.7% | -1.0% | -1.1% |
| Jul 31 | Raymond James | Maintains | Outperform → Outperform | — | $82.96 | $84.75 | +2.2% | +2.3% | -0.1% | +0.7% | -1.0% | -1.1% |
| Jul 18 | Needham | Maintains | Buy → Buy | — | $84.54 | $85.32 | +0.9% | -1.8% | +1.2% | +0.6% | +0.7% | -1.0% |
| Jul 8 | Needham | Maintains | Buy → Buy | — | $91.12 | $93.75 | +2.9% | +4.6% | +0.7% | -0.9% | -1.8% | -0.0% |
| May 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $95.11 | $93.86 | -1.3% | +0.3% | +1.2% | -2.1% | +0.4% | +0.2% |
| May 21 | Wells Fargo | Maintains | Overweight → Overweight | — | $98.81 | $98.07 | -0.7% | -2.3% | -1.4% | +0.3% | +1.2% | -2.1% |
| May 21 | Canaccord Genuity | Maintains | Buy → Buy | — | $98.81 | $98.07 | -0.7% | -2.3% | -1.4% | +0.3% | +1.2% | -2.1% |
| May 20 | Needham | Maintains | Buy → Buy | — | $98.10 | $98.30 | +0.2% | +0.7% | -2.3% | -1.4% | +0.3% | +1.2% |
| May 15 | Needham | Maintains | Buy → Buy | — | $97.01 | $96.76 | -0.3% | +0.6% | +1.3% | -0.7% | +0.7% | -2.3% |
| Apr 25 | Baird | Maintains | Outperform → Outperform | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.9% | -0.7% | -0.3% | -1.3% |
| Apr 25 | Needham | Maintains | Buy → Buy | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.9% | -0.7% | -0.3% | -1.3% |
| Apr 25 | Barrington Research | Maintains | Outperform → Outperform | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.9% | -0.7% | -0.3% | -1.3% |
| Apr 25 | Raymond James | Maintains | Outperform → Outperform | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.9% | -0.7% | -0.3% | -1.3% |
| Apr 25 | Piper Sandler | Maintains | Overweight → Overweight | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.9% | -0.7% | -0.3% | -1.3% |
| Apr 25 | Canaccord Genuity | Maintains | Buy → Buy | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.9% | -0.7% | -0.3% | -1.3% |
| Apr 25 | Wells Fargo | Maintains | Overweight → Overweight | — | $94.67 | $91.00 | -3.9% | -0.1% | +0.9% | -0.7% | -0.3% | -1.3% |
| Apr 23 | Piper Sandler | Maintains | Overweight → Overweight | — | $91.45 | $92.24 | +0.9% | +2.5% | +1.0% | -0.1% | +0.9% | -0.7% |
| Apr 11 | Barrington Research | Maintains | Outperform → Outperform | — | $91.54 | $90.95 | -0.6% | +0.5% | +1.3% | -1.4% | -1.5% | +0.4% |
| Apr 9 | Needham | Maintains | Buy → Buy | — | $88.48 | $87.47 | -1.1% | +8.3% | -4.4% | +0.5% | +1.3% | -1.4% |
| Feb 26 | Needham | Maintains | Buy → Buy | — | $102.03 | $98.53 | -3.4% | -1.5% | -1.9% | +3.6% | +1.0% | -1.1% |
| Feb 26 | Barrington Research | Maintains | Outperform → Outperform | — | $102.03 | $98.53 | -3.4% | -1.5% | -1.9% | +3.6% | +1.0% | -1.1% |
| Feb 26 | Wells Fargo | Maintains | Overweight → Overweight | — | $102.03 | $98.53 | -3.4% | -1.5% | -1.9% | +3.6% | +1.0% | -1.1% |
| Feb 26 | Canaccord Genuity | Maintains | Buy → Buy | — | $102.03 | $98.53 | -3.4% | -1.5% | -1.9% | +3.6% | +1.0% | -1.1% |
| Jan 29 | Barrington Research | Maintains | Outperform → Outperform | — | $109.03 | $110.07 | +1.0% | -0.5% | +1.7% | -1.3% | -1.5% | +0.7% |
| Jan 29 | Needham | Maintains | Buy → Buy | — | $109.03 | $110.07 | +1.0% | -0.5% | +1.7% | -1.3% | -1.5% | +0.7% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| May 11, 2026 | Smith Christian Adam | Chief Commercial Officer | Buy | 1,626 | $61.00 | $99K | 2,220 | -0.10% | +1.13% |
| May 7, 2026 | Ward Lynne N. | — | Sell | 5,000 | $62.61 | $313K | 7,809 | +1.39% | +3.72% |
| May 7, 2026 | Lloyd Brian G. | CHIEF LEGAL OFFICER, SECRETARY | Buy | 2,000 | $62.62 | $125K | 2,000 | +1.39% | +3.72% |
| May 6, 2026 | Aronson Martha Goldberg | President and CEO | Buy | 2,000 | $60.44 | $121K | 49,792 | -1.70% | -0.10% |
| May 6, 2026 | Parra Raul Jr. | CFO AND TREASURER | Buy | 1,500 | $61.01 | $92K | 58,843 | -1.70% | -0.10% |
| May 5, 2026 | Voigt Michel J. | CHIEF HUMAN RESOURCES OFFICER | Buy | 2,250 | $60.65 | $136K | 2,265 | -1.70% | -0.10% |
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Merit Medical disclosed additional revenue breakdown details but signaled it won't repeat this transparency going forward, likely disappointing investors seeking ongoing visibility into product-line performance.
Apr 13
8-K · 7.01
! Medium
Unknown — 8-K 7.01: Regulation FD Disclosure
Merit Medical disclosed forward-looking statements with risk warnings, suggesting upcoming material announcements that may significantly impact stock performance, warranting careful monitoring for competitive, regulatory, or operational developments.
Apr 1
8-K · 7.01
! Medium
Merit Medical Systems Inc -- 8-K 7.01: Regulation FD Disclosure
Merit Medical Systems will host a February 24, 2026 earnings call to discuss Q4 2025 and full-year 2025 results, with live webcast access available.
Feb 24
8-K · 5.02
!!! Very High
Baxter International Inc. -- 8-K 5.02: Executive Change
Baxter International appointed Michael R. McDonnell as Executive Vice President effective February 13, 2026, signaling internal leadership development and potential changes to executive responsibilities.
Feb 12
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Vanguard Portfolio Management Llc | 3,523,088 | $243M | New | Mar 2026 |
| 2 | Morgan Stanley | 2,280,780 | $201M | Added | Dec 2025 |
| 3 | Vanguard Capital Management Llc | 2,656,163 | $183M | New | Mar 2026 |
| 4 | Conestoga Capital Advisors, Llc | 2,167,513 | $149M | Added | Mar 2026 |
| 5 | Citigroup Inc | 1,059,169 | $93M | Added | Dec 2025 |
| 6 | Westwood Holdings Group Inc | 826,214 | $73M | Reduced | Dec 2025 |
| 7 | Congress Asset Management Co | 1,029,249 | $71M | Added | Mar 2026 |
| 8 | Fmr Llc | 1,004,938 | $69M | Reduced | Mar 2026 |
| 9 | Citadel Advisors Llc | 962,784 | $66M | Reduced | Mar 2026 |
| 10 | Royal Bank Of Canada | 921,330 | $64M | Reduced | Mar 2026 |
| 11 | William Blair Investment Management, Llc | 777,494 | $54M | Reduced | Mar 2026 |
| 12 | Point72 Asset Management | 741,942 | $51M | Added | Mar 2026 |
| 13 | Maverick Capital Ltd | 714,081 | $49M | Added | Mar 2026 |
| 14 | Northern Trust Corp | 681,848 | $47M | — | Mar 2026 |
| 15 | Jpmorgan Chase & Co | 617,048 | $42M | Reduced | Mar 2026 |
| 16 | Voya Investment Management Llc | 478,870 | $42M | Reduced | Dec 2025 |
| 17 | Bank Of America Corp /de/ | 580,918 | $40M | Reduced | Mar 2026 |
| 18 | Marshall Wace, Llp | 574,436 | $40M | Added | Mar 2026 |
| 19 | Nuveen, Llc | 546,134 | $38M | Added | Mar 2026 |
| 20 | Wells Fargo & Company/mn | 491,176 | $34M | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$4.06B
Enterprise Value
$4.43B
P/E (TTM)
31.56x
Forward P/E
16.67x
PEG Ratio
8.40x
P/B
2.51x
P/S
2.68x
P/FCF
18.85x
EV/EBITDA
13.33x
Shares Out
60.5M
Financials (TTM)
Revenue
$1.52B
Net Income
$128.5M
EBITDA
$332.0M
Free Cash Flow
$215.7M
Op Cash Flow
$297.4M
EPS Basic
$2.17
EPS Diluted
$2.13
EPS Forward
$4.03
Gross Margin
48.7%
Op Margin
12.2%
Net Margin
8.5%
Balance Sheet
Total Assets
$2.69B
Total Liab.
$1.10B
Total Equity
$1.58B
Cash
$448.5M
LT Debt
$810.7M
Book Value/Sh
$26.78
Debt/Equity
0.57x
Current Ratio
4.34
Quick Ratio
2.95
Returns & Growth
ROE
8.1%
ROA
4.8%
ROIC
5.7%
Rev Growth YoY
+11.8%
EPS Growth YoY
+4.8%
Price Returns
2W
+0.8%
1M
-7.5%
3M
-18.3%
6M
-27.2%
12M
-33.6%
Technicals
52W High
$96.01
52W Low
$60.31
50d MA
$65.30
200d MA
$77.66
RSI (14)
63.10
ATR (14)
$1.94
Beta
0.65
Avg Volume
770K
Dividends
Div Rate
$0.00
Div Yield
—
Frequency
—
Ex-Div Date
—
Analyst Price Targets
Consensus
$100.14
High
$108.00
Low
$78.00
Median
$106.00
Data updated apr 26, 2026 12:43pm
· Source: financialmodelingprep.com